Welcome to the recruiting website for our research study of an investigational drug for people with primary progressive or non-active secondary progressive multiple sclerosis.

Right now, we are looking for people ages 18 to 65 who have been treated with an injected prescribed medication in the past 6 months for primary progressive multiple sclerosis (PPMS) or non-active secondary progressive multiple sclerosis (SPMS).

If you think you or someone you love may be eligible and interested in this study, please continue reading to learn about potential participation.

In this study, there is no placebo (an inactive substance that looks like the investigational drug) group, and all qualified participants will receive the active study treatment.

To see if you may qualify, please complete the pre-qualification questionnaire on the home page.

If you would like to learn more about our study or participation in clinical research studies in general, please scroll down or click on the page links listed above.

To see if you may qualify to participate in our study, please take our pre-qualification questionnaire. If you pre-qualify on the questionnaire, you will have the option to submit your contact information to the nearest participating study center. If you submit your information, the study center staff will contact you for additional information. Based on this information, you may be asked to come to the study center to undergo additional assessments to determine whether you are eligible for the study. You are not obligated to participate in the study at any point in the process.

SEE IF YOU PRE-QUALIFY

Pre-Qualifying Questionnaire

To see if you may qualify for this research study, please complete this Pre-Qualifying Questionnaire.

By clicking to begin the pre-screening process, you allow us to proceed with the pre-screening questions and to begin recording your answers. By clicking you also agree to the terms of the Privacy Policy.

Your name and contact information will not be associated with your answers unless you provide this information after you complete the pre-qualifying questionnaire.

Are you 18 to 65 years of age?

Yes No

How did you hear about this research study

Please enter your home or work zip code. This zip code will be used to locate a study center near you. Please provide the zip code that would be most convenient for you.

Enter 5-digit zip code

Have you been diagnosed with primary progressive multiple sclerosis or non-active secondary progressive multiple sclerosis (non-active SPMS means no relapses in the past 2 years)?

Yes No Unsure

Have you taken a prescribed injected treatment for your PPMS or non-active SPMS in the past 6 months?

Yes No Unsure

Completion Status

PARTICIPATING CITIES

Florida
- Orlando

Why Is This Study Important?

According to the National Institute of Health, multiple sclerosis (MS) is an unpredictable disease of the central nervous system. Primary progressive multiple sclerosis (PPMS) is a type of MS in which symptoms get worse over time, rather than the more common pattern of relapsing-remitting multiple sclerosis (RRMS) (relapses are periods where new symptoms can appear, and previous symptoms can worsen). This means that people with PPMS will usually experience slowly worsening symptoms, with less frequent sudden relapses.

Many people who have RRMS later develop another type of MS called secondary progressive multiple sclerosis (SPMS). SPMS occurs after having RRMS when the symptoms progressively get worse but there is a reduced risk of relapses.

While there have been advances in the treatment of progressive forms of MS, there are limited options to treat either PPMS or non-active SPMS. Many therapies for RRMS are ineffective in slowing progression for PPMS or non-active SPMS. Currently there is only one FDA-approved medication for PPMS, which is an injection taken every six months.

It is important that we conduct research like this that seeks to find more effective medications to help with treating different forms of MS. Conducting such research depends on volunteer participants, which is why we ask for your contact information. If you provide your contact information, we will reach out to you to provide more information about the study so that you can decide if participation is right for you.

To learn more about the study, please click below.

SEE IF YOU PRE-QUALIFY

What Is Clinical Research?

A research study (sometimes called "clinical research" or a "clinical trial") is generally considered to be health-related research in people who have a specific condition, which uses a pre-defined written set of instructions and guidelines (the “protocol”) for how the study is to be conducted.

CLICK HERE TO LEARN MORE ABOUT CLINICAL RESEARCH

Privacy and Confidentiality Policy

A copy of the Data Protection and Privacy Policy for this website is available at this location: Data Protection and Privacy Policy http://tprausa.com/privacy/